|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||2.24 - 2.32|
|52 Week Range||2.21 - 8.77|
|PE Ratio (TTM)||-35.62|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Shares of Rite Aid Corporation (NYSE:RAD) have taken a beating in 2017, falling more than 70% so far on the year. What once looked like a slam dunk in a deal with Walgreens Boots Alliance Inc (NASDAQ:WBA) has now burned investors. After the FTC dragged out the WBA-RAD acquisition, WBA suddenly pulled out of the deal.
Fred's (FRED) is yet to recover from the cancelled Walgreens-Rite Aid merger. The company has also been struggling with declining sales owing to lower comps and store closures.
Amid a 550-job expansion in North Carolina , Asheville-based life sciences company Avadim Technologies has launched one of its products, Theraworx Relief, in Rite Aid and other pharmacies nationwide. Avadim CEO Steve Woody confirmed in an email that this is the first nationwide pharmacy launch for the company. In an announcement, Avadim stated that the U.S. market for Theraworx Relief – a foam or spray for the treatment of muscle spasms and cramps – is 29 million people.